Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer

Serum testosterone is a potential marker to distinguish between indolent and aggressive prostate cancer (PCa). The present study aimed to investigate whether low levels of total serum testosterone at diagnosis were associated with aggressive PCa and poor clinical outcomes. In total, 762 non-Hispanic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Autores principales: Tu, Huakang, Gu, Jian, Meng, Qing H., Kim, Jeri, Strom, Sara, Davis, John W., He, Yonggang, Wagar, Elizabeth A., Thompson, Timothy C., Logothetis, Christopher J., Wu, Xifeng
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403694/
https://ncbi.nlm.nih.gov/pubmed/28454349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5616
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares